🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 372303206
- Market Cap
- Micro Cap
- IPO
- 7/18/2019 · $18.11/share
- ADR Ratio
- 10:1
Business: Genmab A/S is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline, and three proprietary next-generation antibody technologies.
Company Contact
- CEO
- Jan G. J. van de Winkel
- CFO
- Anthony Pagano
- Investor Relations
- acn@genmab.com